menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

5 1
22.01.2025
Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce.

© Fortune


Get it on Google Play